Click on headlines below to download research

Zero overhang
ReNeuron Group | 10/02/2020

The last 16.42% of the former Woodford stake in ReNeuron has now been sold to Obotritia Capital. The rest of the former Woodford stake, 16.58%, is now…

A transformational year
ReNeuron Group | 19/12/2019

2019 has been a transformational year for ReNeuron, marked by impressive initial data from the human retinal progenitor cells (hRPC) programme in retinitis…

FY19 prelims after a momentous second half
ReNeuron Group | 17/07/2019

After a second half punctuated by outstanding interim clinical results and partnering, which together contributed to a c 430% year-to-date share price…